You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for New Drug Application (NDA): 022549


✉ Email this page to a colleague

« Back to Dashboard


NDA 022549 describes ADASUVE, which is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the ADASUVE profile page.

The generic ingredient in ADASUVE is loxapine. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loxapine profile page.
Summary for 022549
Tradename:ADASUVE
Applicant:Alexza Pharms
Ingredient:loxapine
Patents:5
Medical Subject Heading (MeSH) Categories for 022549
Suppliers and Packaging for NDA: 022549
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADASUVE loxapine POWDER;INHALATION 022549 NDA Alexza Pharmaceuticals, Inc. 51097-001 51097-001-02 5 INHALER in 1 CARTON (51097-001-02) / 1 AEROSOL, POWDER in 1 INHALER (51097-001-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength10MG
Approval Date:Dec 21, 2012TE:RLD:Yes
Patent:7,458,374Patent Expiration:Aug 18, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:7,537,009Patent Expiration:Oct 28, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:8,387,612Patent Expiration:Oct 23, 2026Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 022549

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 7,585,493 ⤷  Subscribe
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 9,440,034 ⤷  Subscribe
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 6,716,416 ⤷  Subscribe
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 8,235,037 ⤷  Subscribe
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 8,173,107 ⤷  Subscribe
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 9,439,907 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.